CD4 and type 1 diabetes mellitus: We explored this possibility initially in two autoimmune patient cohorts, isolating CD4+ T-cells from rheumatoid arthritis (RA) and type 1 diabetes (T1D) patients and activating them in the presence and absence of ML-226 ex vivo (Fig. 5a).